Federal workers' families lose health coverage for gender care

What it does

This bill amends the Federal Employees Health Benefits (FEHB) program to prohibit coverage of gender-affirming medical care—including hormone therapy, puberty blockers, and surgical procedures—for individuals under 18 years old. It carves out exceptions for intersex conditions, treatment of complications from prior medical interventions, life-threatening emergencies, and standard puberty treatments for precocious or delayed puberty. Minors already receiving covered hormone therapy as of the bill's enactment may continue for up to one year on a physician-supervised reduction schedule.

Why we flagged it

The bill's operative mechanism is a categorical exclusion from federal employee health insurance for a specific class of medical treatment for minors. It is not a safety measure, transparency requirement, or fraud prevention—it is a coverage denial.

What the text implies

• The bill applies only to FEHB (federal employee plans), not to Medicare, Medicaid, or private insurance, creating a two-tier system where federal workers' families have fewer treatment options than other Americans—potentially incentivizing federal employees to seek private coverage or out-of-pocket care.
• The one-year wind-down provision for minors already in treatment may force abrupt cessation of ongoing medical care, creating medical and psychological discontinuity for vulnerable patients mid-treatment.
• The definition of gender-affirming care is broad enough to potentially capture hormone therapies used for non-gender-dysphoria conditions if administered off-label, depending on plan interpretation.
• No provision addresses how plans will verify compliance or handle disputes over whether a treatment falls within the carve-outs (e.g., whether a hormone therapy is truly for 'delayed puberty' vs. gender dysphoria).
• The bill does not require plans to cover alternative mental-health or supportive services for minors with gender dysphoria, potentially leaving them without any covered treatment pathway.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill restricts access to a category of medical care for a vulnerable population (minors) by removing it from federal employee health plans, reducing treatment options available to federal workers' families and potentially setting a precedent for other public and private insurers. The carve-outs for intersex and emergency conditions are narrow and do not offset the broad exclusion.

Named in the bill

Federal Employees Health Benefits (FEHB) program, Title 5 United States Code, Senate Committee on Homeland Security and Governmental Affairs

Where it stands

3 cosponsors: 3 Republicans.

• May 15, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• May 15, 2025 — Referred to Senate Committee on Homeland Security and Governmental Affairs · Congress.gov: “Read twice and referred to the Committee on Homeland Security and Governmental Affairs”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $439,908 in lobbying spend. A filing names 132 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

James Risch, the sponsor, reported $1,209,927 in PAC receipts in the 2026 cycle.

• Human Rights Campaign — $439,908 on 2 filings

Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.